OnCusp Therapeutics
Operator of a biopharmaceutical company intended to discover clinically validated treatments for cancer patients worldwide. The company is dedicated to the translation and clinical development of onco...
Valuation
$0
Share Price
N/A
Total Raised
$175.8M
Last Round
N/A